NCT07431489
- Conditions
- MEK Inhibitor-Associated Retinopathy, Malignant Melanoma, Melanoma, +11 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia
Clinical trial condition
MEK Inhibitor-Associated Retinopathy
Explore clinical trials studying MEK Inhibitor-Associated Retinopathy. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies